Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Uipath stock
Learn how to easily invest in Uipath stock.
Uipath Inc is a software-infrastructure business based in the US. Uipath shares (PATH) are listed on the NYSE and all prices are listed in US Dollars.
How to buy shares in Uipath
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PATH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Uipath stock price (NYSE: PATH)Use our graph to track the performance of PATH stocks over time.
Uipath shares at a glance
|Latest market close||$20.55|
|52-week range||$13.66 - $69.60|
|50-day moving average||$18.23|
|200-day moving average||$35.04|
|Wall St. target price||$29.60|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.76|
Buy Uipath shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Uipath stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Uipath price performance over time
|1 week (2022-06-28)||2.65%|
|1 month (2022-06-03)||N/A|
|3 months (2022-04-04)||-9.83%|
|6 months (2022-01-07)||-47.58%|
|1 year (2021-07-07)||-69.15%|
|2 years (2020-07-03)||N/A|
|3 years (2019-07-03)||N/A|
|5 years (2017-07-03)||N/A|
Is Uipath stock undervalued or overvalued?
Valuing Uipath stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Uipath's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Uipath's PEG ratio
Uipath's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 33.1886. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Uipath's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Uipath's PEG ratio in relation to those of similar companies.
|Revenue TTM||$951.1 million|
|Gross profit TTM||$723.4 million|
|Return on assets TTM||-10.06%|
|Return on equity TTM||-21.61%|
|Market capitalisation||$10.2 billion|
TTM: trailing 12 months
Uipath share dividends
We're not expecting Uipath to pay a dividend over the next 12 months.
You may also wish to consider:
- Pegasystems (PEGA.US) (0.25% forward annual dividend yield)
UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform combines artificial intelligence with desktop recording, back-end mining of both human activity and system logs, and intuitive visualization tools, which enables users to discover, analyze, and identify processes to automate in a centralized portal; offers low-code development environments that allows users in an organization to create attended and unattended automations without any prior knowledge of coding; deploys robots in highly immersive attended experiences or in standalone, unattended modes behind the scenes, and can leverage native connectors built for commonly used line-of-business applications; offers centralized tools designed to manage, test, and deploy automations and ML models across the enterprise; allows customers to manage long running processes that orchestrate work between robots and humans; and enable users to track, measure, and forecast the performance of automation in their enterprise and help businesses ensure compliance with business standards. In addition, the company provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. It serves banking, healthcare, financial services, and government entities. UiPath Inc.
Uipath in the news
Top 10 Stock Picks of Jose Fernandez’s Stepstone Group
Could UiPath Become the Next Microsoft?
Cathie Wood’s Latest Thoughts on Inflation and Her 10 Worst-Performing Stock Picks
Frequently asked questionsWhat percentage of Uipath is owned by insiders or institutions?
Currently 11.326% of Uipath shares are held by insiders and 53.725% by institutions. When does the fiscal year end for Uipath?
Uipath's fiscal year ends in January. Where is Uipath based?
Uipath's address is: 452 5th Avenue, New York, NY, United States, 10018 What is Uipath's ISIN number?
Uipath's international securities identification number is: US90364P1057
More guides on Finder
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert